Parasternal Blockade and Serum Lactate in Cardiac Surgery

ConditionElective Cardiac Surgery

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorInstituto Mexicano del Seguro Social

About this trial

Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients older than 18 years

Either sex

ASA II-III

Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.

Disqualifiers

Patients with pre-existing conditions that could independently affect serum lactate levels.

Trial design

Design model

Parallel

Treatments tested in this trial

Parasternal block
Procedure/Surgery
In the case-control groups, patients with elevated serum lactate levels above 2 mmol/L and those who remained below this limit will be identified.
Requirement of total dose regarding fentanyl
Procedure/Surgery
In case-control groups, obtain measurement of total postoperative fentanyl requirement.

Treatment groups

86 Participants

are divided into 2 treatment groups

Group A: Case groupExperimental treatment 2 interventions

Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

Serum lactate measurement

Elevated serum lactate levels above 2 mmol/L

Time frame

24 hours postoperative

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Instituto Mexicano del Seguro Social

Lead sponsor

Source ClinicalTrials.gov

Apply now